NAMODENOSON
UNII Z07JR07J6C

Substance Identification & Data

This profile provides standardized clinical and technical data for Namodenoson, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Z07JR07J6C.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 163042-96-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

Z07JR07J6C

CAS Registry Number

163042-96-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

NAMODENOSON

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C18H18ClIN6O4

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

IPSYPUKKXMNCNQ-PFHKOEEOSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C79826

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

3035850

Unique identification number in the NCBI database of chemical substances.

INN ID

10651

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

DE-95

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

n1(c2nc(nc(NCc3cc(ccc3)I)c2nc1)Cl)[C@H]4[C@@H]([C@@H]([C@H](O4)C(NC)=O)O)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Namodenoson. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.